Pandit-Taskar N - Search Results

1

¹⁸F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.

Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, Srivastava A, Tang LH, Schoder H, Janjigian YY. Cytryn SL, et al. J Nucl Med. 2024 May 1;65(5):722-727. doi: 10.2967/jnumed.123.267186. J Nucl Med. 2024. PMID: 38514081 Free PMC article.

2

Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival.

Sala E, Kataoka M, Pandit-Taskar N, Ishill N, Mironov S, Moskowitz CS, Mironov O, Collins MA, Chi DS, Larson S, Hricak H. Sala E, et al. Radiology. 2010 Oct;257(1):125-34. doi: 10.1148/radiol.10092279. Epub 2010 Aug 9. Radiology. 2010. PMID: 20697116 Free PMC article.

3

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.

Ott PA, Carvajal RD, Pandit-Taskar N, Jungbluth AA, Hoffman EW, Wu BW, Bomalaski JS, Venhaus R, Pan L, Old LJ, Pavlick AC, Wolchok JD. Ott PA, et al. Invest New Drugs. 2013 Apr;31(2):425-34. doi: 10.1007/s10637-012-9862-2. Epub 2012 Aug 5. Invest New Drugs. 2013. PMID: 22864522 Free PMC article. Clinical Trial.

4

Primary seminal vesicle adenocarcinoma.

Navallas M, Vargas HA, Akin O, Pandit-Taskar N, Fine SW, Eastham JA, Hricak H. Navallas M, et al. Clin Imaging. 2011 Nov-Dec;35(6):480-2. doi: 10.1016/j.clinimag.2011.02.004. Clin Imaging. 2011. PMID: 22040796

5

ACR Appropriateness Criteria ® spinal bone metastases.

Expert Panel on Radiation Oncology-Bone Metastases; Lo SS, Lutz ST, Chang EL, Galanopoulos N, Howell DD, Kim EY, Konski AA, Pandit-Taskar ND, Rose PS, Ryu S, Silverman LN, Sloan AE, Van Poznak C. Expert Panel on Radiation Oncology-Bone Metastases, et al. J Palliat Med. 2013 Jan;16(1):9-19. doi: 10.1089/jpm.2012.0376. Epub 2012 Nov 20. J Palliat Med. 2013. PMID: 23167547 Free article.

6

Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma.

Karakousis GC, Pandit-Taskar N, Hsu M, Panageas K, Atherton S, Ariyan C, Brady MS. Karakousis GC, et al. Melanoma Res. 2013 Feb;23(1):40-6. doi: 10.1097/CMR.0b013e32835d5062. Melanoma Res. 2013. PMID: 23250048

7

Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.

Pandit-Taskar N, Schöder H, Gonen M, Larson SM, Yeung HW. Pandit-Taskar N, et al. AJR Am J Roentgenol. 2004 Oct;183(4):1143-7. doi: 10.2214/ajr.183.4.1831143. AJR Am J Roentgenol. 2004. PMID: 15385321

8

Oncologic imaging in gynecologic malignancies.

Pandit-Taskar N. Pandit-Taskar N. J Nucl Med. 2005 Nov;46(11):1842-50. J Nucl Med. 2005. PMID: 16269598 Free article. Review.

9

Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients.

Pandit-Taskar N, Dauer LT, Montgomery L, St Germain J, Zanzonico PB, Divgi CR. Pandit-Taskar N, et al. J Nucl Med. 2006 Jul;47(7):1202-8. J Nucl Med. 2006. PMID: 16818956 Free article.

10

Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy.

Pandit-Taskar N, O'Donoghue JA, Morris MJ, Wills EA, Schwartz LH, Gonen M, Scher HI, Larson SM, Divgi CR. Pandit-Taskar N, et al. J Nucl Med. 2008 Jul;49(7):1066-74. doi: 10.2967/jnumed.107.049502. Epub 2008 Jun 13. J Nucl Med. 2008. PMID: 18552139 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters